Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Raw Materials (2019 - 2025)

Historic Raw Materials for CorMedix (CRMD) over the last 6 years, with Q3 2025 value amounting to $7.0 million.

  • CorMedix's Raw Materials rose 106274.66% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year increase of 106274.66%. This contributed to the annual value of $1.1 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, CorMedix's Raw Materials stood at $7.0 million, which was up 106274.66% from $1.1 million recorded in Q2 2025.
  • CorMedix's Raw Materials' 5-year high stood at $7.0 million during Q3 2025, with a 5-year trough of $603545.0 in Q3 2024.